The role of pelvic and aortic lymphadenectomy at second look surgery in apparent early stage ovarian cancer after inadequate surgical staging followed by adjuvant chemotherapy

2014 ◽  
Vol 132 (2) ◽  
pp. 312-315 ◽  
Author(s):  
Mauro Signorelli ◽  
Robert Fruscio ◽  
Lorenzo Ceppi ◽  
Tiziana Dell'Anna ◽  
Domenico Vitobello ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Adjuvant Chemotherapy ◽  
Early Stage ◽  
Surgical Staging ◽  
Second Look ◽  
Early Stage Ovarian Cancer

scholarly journals Effect of chemotherapy on health-related quality of life among early-stage ovarian cancer survivors: a study from the population-based PROFILES registry

2016 ◽  
Vol 23 (6) ◽  
pp. 556 ◽  
Author(s):  
C.S. Bhugwandass ◽  
J.M.A. Pijnenborg ◽  
B. Pijlman ◽  
N.P.M. Ezendam
Keyword(s):  
Quality Of Life ◽  
Ovarian Cancer ◽  
Adjuvant Chemotherapy ◽  
Early Stage ◽  
Population Based ◽  
Health Related Quality ◽  
Related Quality ◽  
Health Related ◽  
Early Stage Ovarian Cancer

Background There is wide variation in the application of adjuvant chemotherapy in early-stage epithelial ovarian cancer. Our aim was to assess differences in health-related quality of life (hrqol) between patients with early-stage ovarian cancer who did or did not receive chemotherapy as adjuvant treatment.Methods All patients diagnosed with early-stage ovarian cancer between 2000 and 2010 within the population-based Eindhoven Cancer Registry (n = 191) were enrolled in this study. Patients were requested to complete questionnaires, including the cancer-specific (qlq-C30) and ovarian cancer-specific (qlq-OV28) quality of life measures from the European Organisation for Research and Treatment of Cancer. Primary outcome measures were the generic- and cancer-specific domain scores for hrqol in ovarian cancer survivors.Results Of the 107 patients (56%) who returned the questionnaires, 57 (53.3%) had received adjuvant chemotherapy and 50 (46.7%) had been treated with surgery alone. Significant differences in hrqol between those groups were found in the symptom scales for peripheral neuropathy, attitude toward sickness, and financial situation, with worse scores in the chemotherapy group.Conclusions Results of our study show that patients who receive adjuvant chemotherapy have a significantly worse score for 3 aspects of hrqol. Efforts should be made to reduce use of adjuvant chemotherapy in early-stage ovarian cancer. Moreover, preventive strategies to improve long-term quality of life for those who need adjuvant chemotherapy should be explored.

The Role of Omentectomy and Random Peritoneal Biopsies as Part of Comprehensive Surgical Staging in Apparent Early-Stage Epithelial Ovarian Cancer

2014 ◽  
Vol 21 (8) ◽  
pp. 2762-2766 ◽  
Author(s):  
Jung-Yun Lee ◽  
Hee Seung Kim ◽  
Hyun Hoon Chung ◽  
Jae Weon Kim ◽  
Noh Hyun Park ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Epithelial Ovarian Cancer ◽  
Early Stage ◽  
Surgical Staging

scholarly journals Incomplete Surgical Staging in Clinical Early-Stage Ovarian Cancer: Guidelines Versus Daily Practice

2021 ◽  
Author(s):  
Pim Laven ◽  
Jogchem Beltman ◽  
Joelle Bense ◽  
Maaike van der Aa ◽  
Toon Van Gorp ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Early Stage ◽  
Daily Practice ◽  
Surgical Staging ◽  
Cancer Guidelines ◽  
Early Stage Ovarian Cancer

Adequacy of surgical staging to predict survival in early stage ovarian cancer.

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. e17037-e17037
Author(s):  
Rachel Hope Occhiogrosso ◽  
Margaret Steinhoff ◽  
Christina Raker ◽  
Phinnara Has ◽  
Paul DiSilvestro
Keyword(s):  
Ovarian Cancer ◽  
Early Stage ◽  
Surgical Staging ◽  
Early Stage Ovarian Cancer
Sign in / Sign up

Export Citation Format

Share Document